Cullen/Frost Bankers’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Sell
3,675
-79
-2% -$44.3K 0.02% 280
2026
Q1
$2.11M Buy
3,754
+101
+3% +$64.8K 0.02% 274
2025
Q4
$2.47M Buy
3,653
+103
+3% +$70.1K 0.03% 264
2025
Q3
$2.27M Sell
3,550
-4
-0.1% -$2.43K 0.03% 258
2025
Q2
$1.91M Hold
3,554
0.02% 263
2025
Q1
$1.49M Sell
3,554
-63
-2% -$27.4K 0.02% 271
2024
Q4
$1.5M Buy
3,617
+52
+1% +$22.8K 0.02% 267
2024
Q3
$1.8M Buy
3,565
+7
+0.2% +$3.4K 0.02% 249
2024
Q2
$1.73M Buy
3,558
+8
+0.2% +$4.02K 0.03% 250
2024
Q1
$1.92M Hold
3,550
0.03% 249
2023
Q4
$1.97M Sell
3,550
-88
-2% -$41.3K 0.03% 243
2023
Q3
$1.59M Sell
3,638
-31
-0.8% -$15.5K 0.03% 266
2023
Q2
$1.84M Buy
3,669
+3,541
+2,766% +$1.7M 0.03% 257
2023
Q1
$64K Sell
128
-67
-34% -$32.1K ﹤0.01% 681
2022
Q4
$79.6K Sell
195
-1,164
-86% -$452K ﹤0.01% 637
2022
Q3
$443K Hold
1,359
0.01% 393
2022
Q2
$477K Buy
1,359
+1,154
+563% +$471K 0.01% 382
2022
Q1
$112K Buy
205
+3
+1% +$1.58K ﹤0.01% 613
2021
Q4
$133K Sell
202
-49
-20% -$30.8K ﹤0.01% 590
2021
Q3
$156K Hold
251
﹤0.01% 563
2021
Q2
$159K Buy
251
+44
+21% +$24.3K ﹤0.01% 567
2021
Q1
$101K Sell
207
-72
-26% -$36.1K ﹤0.01% 609
2020
Q4
$139K Buy
279
+100
+56% +$44.7K ﹤0.01% 538
2020
Q3
$70K Buy
179
+70
+64% +$25.9K ﹤0.01% 607
2020
Q2
$36K Buy
+109
New +$31.6K ﹤0.01% 717
2020
Q1
Sell
-3
Closed -$1K 960
2019
Q4
$1K Buy
+3
New +$791 ﹤0.01% 1016

Other funds holding IDXX

Cullen/Frost Bankers's IDXX Position: Q2 2026 in Review

Cullen/Frost Bankers reduced its Idexx Laboratories (IDXX) stake by 2.1% in Q2 2026, selling an estimated $44.3K and leaving 3,675 shares worth $1.93M. The position accounts for 0.02% of the portfolio, ranked #280.

Cullen/Frost Bankers first reported a position in IDXX in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.47M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cullen/Frost Bankers held 3,675 shares of Idexx Laboratories worth $1.93M as of Q2 2026.
  • Cullen/Frost Bankers sold 79 Idexx Laboratories shares in Q2 2026, an estimated $44.3K.
  • Idexx Laboratories made up 0.02% of Cullen/Frost Bankers's portfolio in Q2 2026, its #280 holding.
  • Cullen/Frost Bankers first reported a position in Idexx Laboratories in Q4 2019 and has held it in 26 quarters since.
  • Cullen/Frost Bankers's Idexx Laboratories position peaked at $2.47M in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.